ANI Pharmaceuticals reported $8.14M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
AbbVie USD 938M 348M Jun/2025
ANI Pharmaceuticals USD 8.14M 7.54M Jun/2025
Aurora Cannabis CAD -15210000 46.88M Jun/2025
Canopy Growth CAD -41530000 80.37M Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
Hikma Pharmaceutical USD 133M 93M Dec/2024
Knight Therapeutics CAD 85K 2.03M Sep/2024
Novartis USD 4.04B 1.22B Jun/2025
Perrigo USD -8400000 2M Jun/2025
Sun Pharmaceuticals INR 22.79B 1.29B Jun/2025
Teva Pharmaceutical Industries USD 282M 68M Jun/2025